STING1 and breast cancer: Interestingly, while the chemotherapy-induced secretome of MCF7 cells reduced the viability of treatment naïve cancer cells, the activation of the STING pathway in breast cancer cells made them more resistant to genotoxic stress caused by mafosfamide (Gaston et al. 2016).